Item – Thèses Canada

​
Numéro d'OCLC
1033019345
Lien(s) vers le texte intégral
Exemplaire de BAC
Exemplaire de BAC
Auteur
Aguileta, Miguel.
Titre
Parkin interacts with the 26S proteasome via Rpn13, a novel ubiquitin receptor.
Diplôme
Master of Science -- McGill University, 2011
Éditeur
Montréal : McGill University, 2011.
Description
1 online resource
Notes
Includes bibliographical references.
All items in eScholarship|McGill are protected by copyright with all rights reserved unless otherwise indicated.
Résumé
Mutations in the Parkin gene cause a juvenile-onset for of Parkinson's disease (PD) that is transmitted in an autosomal recessive way. Studies have shown that mutations in parkin account for almost 50% of all juvenile-onset forms of PD, making parkin one of the most studied genes as a causative factor for PD.Ubiquitin (Ub), a small 76 amino acid protein, can be covalently attached to other proteins. This post-translational modification is used as a signal for degradation in the ubiquitin-proteasome pathway (UPP). Ubiquitination requires the concerted activity of 3 basic enzymes: Ub-activaying enzyme (E1), Ub-conjugating enzyme (E2) and Ub-ligase (E3).Studies have shown that parkin functions as a RING type Ub ligase, thus targeting potentially toxic proteins for degradation in the UPP. Parkin's E3 ligase activity is linked to its C-terminal RING1-IBR-RING2 domain. However, the function of its N-terminal ubiquitin-like domain (Ubl) remains unclear. Here, we present evidence suggesting that parkin's Ubl domain mediates an interaction between parkin and the proteasome, specifically Rpn13, a novel ubiquitin receptor.
Autre lien(s)
digitool.library.mcgill.ca
escholarship.mcgill.ca
escholarship.mcgill.ca
Sujet
Biology - Neuroscience.